First Wave Bio (FWBI)

First Wave Bio (FWBI) Stock Price & Analysis


FWBI Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.27 - $16.38
Previous Close$0.29
Average Volume (3M)3.69M
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$1.24M
Total Debt (Recent Filing)$401.70K
Price to Earnings (P/E)<0.1
Aug 13, 2019
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)10.52
Shares Outstanding7,152,204
10 Day Avg. Volume1,281,329
30 Day Avg. Volume3,689,182
Standard Deviation0.26
Financial Highlights & Ratios
Price to Book (P/B)-2.67
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was First Wave Bio’s price range in the past 12 months?
First Wave Bio lowest stock price was $0.27 and its highest was $16.38 in the past 12 months.
    What is First Wave Bio’s market cap?
    Currently, no data Available
    When is First Wave Bio’s upcoming earnings report date?
    First Wave Bio’s upcoming earnings report date is Aug 13, 2019 which is 1509 days ago.
      How were First Wave Bio’s earnings last quarter?
      Currently, no data Available
      Is First Wave Bio overvalued?
      According to Wall Street analysts First Wave Bio’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does First Wave Bio pay dividends?
        First Wave Bio does not currently pay dividends.
        What is First Wave Bio’s EPS estimate?
        First Wave Bio’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does First Wave Bio have?
        First Wave Bio has 13,463,479 shares outstanding.
          What happened to First Wave Bio’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of First Wave Bio?
          Currently, no hedge funds are holding shares in FWBI


          First Wave Bio Stock Smart Score

          This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
          Learn more about TipRanks Smart Score

          Company Description

          First Wave Bio

          AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. It focuses on MS1819-SD, and B-Lactamase program products. The company was founded on January 30, 2014 and is headquartered in Brooklyn, NY.


          Top 5 ETFs holding FWBI

          Market Value
          Smart Score
          iShares Core S&P Total U.S. Stock Market ETF
          Up to five ETFs with an Outperform Smart Score that hold FWBI. The ETFs are listed according to market value of FWBI within the ETF

          Forecast EPS vs Actual EPS

          Similar Stocks
          Price & Change
          Infinity Pharma
          DMK Pharmaceuticals
          Cyclacel Pharmaceuticals

          Popular Stocks

          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis